FindTrial
Sign In

Myokine Gene Expression Screening In Osteosarcoma

Myokine Gene Expression Screening In Osteosarcoma

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR-ROC-17012582
Enrollment
Unknown
Registered
2017-09-05
Start date
2017-09-11
Completion date
Unknown
Last updated
2017-09-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

osteosarcoma

Interventions

osteosarcoma tissues:surgery
peritumoral muscle tissues :surgery
bone tissues:surgery

Sponsors

Shanghai Jiao Tong University Affiliated Sixth People's Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
7 Years to 69 Years

Inclusion criteria

Inclusion criteria: 1. Osteosarcoma patients had not progressed chemotherapy preoperatively or progressed chemotherapytumor but necrosis rate is below 50%; 2. No long-term use of steroid drugs; 3. Aged<70 years.

Exclusion criteria

Exclusion criteria: 1. Osteosarcoma patients progressed chemotherapytumor preoperatively and necrosis rate is equal or over 50%; 2. Long-term use of steroid drugs.

Design outcomes

Primary

MeasureTime frame
mRNA expression;—

Countries

China

Contacts

Public ContactZhou Shumin

Department of orthopaedics, Shanghai Jiao Tong University Affiliated Sixth People’s Hospital

zhoushumin_zw@126.com+86 18502127296

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026